Thailand was the world’s fourth-largest medical tourism destination in 2017, with a market value of around USD 600 million.
Made with Visme Infographic Maker
written on 03.09.2019
Thailand Medical Tourism Snapshot
Similar Facts and Figures
Thailand / Top 10 Pharma Companies
The top ten companies in the USD 6.9 billion Thai pharma market for 2021 ranked by market share, compiled by Thai banking firm Krungsti. Three of the featured firms –…
Thailand Pharma Market Snapshot 2019
The Thai pharma market, one of the largest in the ASEAN region, stood at USD 4.6 billion in size in 2016. A recent report from the Dutch Embassy in Thailand…
Medical Tourism Top Five Countries
Click here to read more articles and interviews from Thailand, and to download the latest free pharma report on the country.
Thailand Medtech Overview 2019
Thailand’s medical devices (medtech) market is projected to grow from USD 1.2 billion in 2016 to 1.7 billion in 2020, representing a CAGR of 8.1%. Made with Visme Infographic Maker…
Health Expenditure in Asia
Click here to read more articles and interviews from Thailand, and to download the latest free pharma report on the country.
Thailand Healthcare Snapshot 2019
Thailand’s healthcare expenditure is projected to rise from USD 25.3 billion in 2016 to 47.9 billion by 2026, a ten-year CAGR of 6.6%. Made with Visme Infographic Maker According…
Southeast Asia / More Indonesian License Suspensions; Kalbe's Aventis Share Purchase; Boston Scientific's Malaysia Expansion
The biggest pharma stories from Southeast Asia, including GSK’s new HPF manufacturing investment, license suspensions for Samco Farma and Ciubros Farma after Indonesia’s acute kidney injury crisis, Kalbe’s Aventis share…
APAC / Evolving Compassionate Use and Named Patient Programs
Through compassionate use programs patients suffering from critical, life-threatening conditions can access potential life-saving therapeutic options which have not been formally approved by the responsible health authority in an ethical…
ASEAN / Regulatory Cooperation & Joint Assessments
Writing in the September edition of DIA’s Global Forum magazine, Rosilawati Ahmad of Malaysia’s National Pharmaceutical Regulatory Agency; Tharnkamol Chanprapaph of the Thai FDA; and Samvel Azatyan, Valerio Reggi, and…